Corcept's Phase 3 GRADIENT trial for relacorilant has missed its primary endpoint – the improvement in SBP for Cushing's ...

Corcept Therapeutics Inc. (CORT), which posted strong financial results for the third quarter yesterday, is anticipating a ...

Salivary cortisol measurements are particularly useful to investigate cyclical Cushing's syndrome. At least partial autonomy of cortisol production (either direct from the adrenal cortex or ...

More recently, a prospective, multicenter pilot study evaluated the effectiveness of retinoic acid in the treatment of Cushing's syndrome. Seven patients with Cushing's disease were initiated on ...

Corcept Therapeutics announced Wednesday that its experimental treatment for Cushing’s syndrome missed the primary endpoint ...

CORT beats on both earnings and sales in the third quarter of 2024. The company increases the revenue guidance for 2024. Stock falls in after-hours trading.

By the time he died, Henry VIII was plagued by illness, frequently depressed, suffered violent mood swings and was ...

Sabrina Gomes, 24, has seen her skin get progressively darker since having a surgical procedure two years ago, but has had to fight in court to get the expensive treatment that could reverse it ...

In Nebraska, the only state with competing pro-life and pro-abortion ballot measures, Archbishop George Lucas of Omaha urged ...

Louisiana health care workers and advocates filed a lawsuit Thursday challenging a recently passed state law reclassifying ...

Corcept Therapeutics ( (CORT) ) has shared an announcement. Corcept Therapeutics reported a 48% boost in third-quarter revenue, reaching ...

Grapefruit can interact with many medications, potentially affecting the way they work or increasing side effects. Some of ...